These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 9886376)
1. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; Jirillo E; McGhee JR J Immunol; 1999 Jan; 162(1):114-21. PubMed ID: 9886376 [TBL] [Abstract][Full Text] [Related]
2. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461 [TBL] [Abstract][Full Text] [Related]
3. IL-12 is an effective adjuvant for induction of mucosal immunity. Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377 [TBL] [Abstract][Full Text] [Related]
4. Mucosal immunity: regulation by helper T cells and a novel method for detection. Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406 [TBL] [Abstract][Full Text] [Related]
5. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. Marinaro M; Boyaka PN; Finkelman FD; Kiyono H; Jackson RJ; Jirillo E; McGhee JR J Exp Med; 1997 Feb; 185(3):415-27. PubMed ID: 9053442 [TBL] [Abstract][Full Text] [Related]
6. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Strindelius L; Filler M; Sjöholm I Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861 [TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814 [TBL] [Abstract][Full Text] [Related]
8. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. Imaoka K; Miller CJ; Kubota M; McChesney MB; Lohman B; Yamamoto M; Fujihashi K; Someya K; Honda M; McGhee JR; Kiyono H J Immunol; 1998 Dec; 161(11):5952-8. PubMed ID: 9834076 [TBL] [Abstract][Full Text] [Related]
9. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550 [TBL] [Abstract][Full Text] [Related]
10. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254 [TBL] [Abstract][Full Text] [Related]
11. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651 [TBL] [Abstract][Full Text] [Related]
12. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. McCluskie MJ; Davis HL J Immunol; 1998 Nov; 161(9):4463-6. PubMed ID: 9794366 [TBL] [Abstract][Full Text] [Related]
13. In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokine and antibody production. Rempel JD; Wang M; HayGlass KT J Immunol; 1997 Aug; 159(3):1490-6. PubMed ID: 9233648 [TBL] [Abstract][Full Text] [Related]
14. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation. Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497 [TBL] [Abstract][Full Text] [Related]
15. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081 [TBL] [Abstract][Full Text] [Related]
16. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice. Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126 [TBL] [Abstract][Full Text] [Related]
17. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates. Kubota M; Miller CJ; Imaoka K; Kawabata S; Fujihashi K; McGhee JR; Kiyono H J Immunol; 1997 Jun; 158(11):5321-9. PubMed ID: 9164952 [TBL] [Abstract][Full Text] [Related]
18. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936 [TBL] [Abstract][Full Text] [Related]
19. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627 [TBL] [Abstract][Full Text] [Related]
20. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice. Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]